朗生医药二零二三年中期报告

INTERIM REPORT2023 2CORPORATE INFORMATION 5FINANCIAL HIGHLIGHTS 6MANAGEMENT DISCUSSION AND ANALYSIS 18OTHER INFORMATION 23REPORT ON REVIEW OF CONDENSED CONSOLIDATED INTERIMFINANCIAL STATEMENTS 25CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS ANDOTHER COMPREHENSIVE INCOME 27CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION 29CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY 31CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS 32NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS 企 業 資 料Corporate Information BOARD OF DIRECTORSExecutive Managing Director:Mr. Chen Li(Chief Executive Officer) Non-executive Directors:Mr. Wu Zhen Tao(Chairman)Ms. Liu Xuezi Independent non-executive Directors: Mr. Chan Kee Huen, MichaelMr. Yeung Tak Bun, AllenMs. Chan Ching Har, ElizaDr. Zhu Xun AUDIT COMMITTEE Mr. Chan Kee Huen, Michael(Chairman)Mr. Yeung Tak Bun, AllenMs. Chan Ching Har, Eliza REMUNERATION COMMITTEE Mr. Yeung Tak Bun, Allen(Chairman)Mr. Chan Kee Huen, MichaelDr. Zhu Xun NOMINATION COMMITTEE Mr. Wu Zhen Tao(Chairman)Mr. Chan Kee Huen, MichaelMr. Yeung Tak Bun, Allen EXECUTIVE COMMITTEE Mr. Wu Zhen Tao(Chairman)Mr. Chen LiMs. Liu XueziMs. Tao Fang Fang 企 業 資 料Corporate Information AUTHORISED REPRESENTATIVES Mr. Chen LiMr. Pang Kai Fai COMPANY SECRETARYMr. Pang Kai Fai REGISTERED OFFICE Windward 3, Regatta Office ParkP.O. Box 1350Grand CaymanKY1-1108Cayman Islands Windward 3, Regatta Office ParkP.O. Box 1350Grand CaymanKY1-1108Cayman Islands HEADQUARTERS AND PRINCIPAL PLACE OFBUSINESS IN THE PRC 228 Xinfeng RoadGaoqiao Industrial ParkHaishu District, Ningbo CityZhejiang ProvincePRCPostal Code: 315174 228315174 PRINCIPAL PLACE OF BUSINESS IN HONG KONG Suites 1203–412/F., Li Po Chun Chambers189 Des Voeux Road CentralHong Kong 189121203–4 AUDITOR BDO LimitedCertified Public AccountantsRegistered Public Interest Entity Auditor LEGAL ADVISORS Stephenson Harwood (Hong Kong)Ocorian Trust (Cayman Islands) Ocorian Trust PRINCIPAL BANKERS Agricultural Bank of ChinaChina CITIC BankChina Merchants BankSPD BankChina Guangfa BankUnited Overseas Bank 企 業 資 料 Corporate Information PRINCIPAL SHARE REGISTRAR AND TRANSFEROFFICE Ocorian Trust (Cayman) LimitedWindward 3, Regatta Office ParkP.O. Box 1350Grand CaymanKY1-1108Cayman Islands Ocorian Trust (Cayman) LimitedWindward 3, Regatta Office ParkP.O. Box 1350Grand CaymanKY1-1108Cayman Islands HONG KONG BRANCH SHARE REGISTRAR Link Market Services (Hong Kong) Pty LimitedSuite 1601, 16/F, Central Tower28 Queen’s Road CentralHong Kong Link Market Services (Hong Kong) Pty Limited28161601 STOCK CODE503 503 WEBSITEwww.lansen.com.cn www.lansen.com.cn CORPORATE CONTACT INFORMATION FORSHAREHOLDERS AND INVESTORS (852) 2828 9206 Hong KongPlease contact our Company Secretary at:Telephone: (852) 2828 9206 The PRC (86) 574 8804 6316 Please contact our Investor Relations Department at:Telephone: (86) 574 8804 6316 財 務 摘 要Financial Highlights 管 理 層 討 論 及 分 析Management Discussion and Analysis The principal activities of Lansen Pharmaceutical Holdings Limited(the “Company”) and its subsidiaries (hereinafter collectively knownas “Lansen” or the “Group”) are classified into three segments,pharmaceutical, healthcare and cosmetic. Its products are mainly soldin the People’s Republic of China (the “PRC”). Business Review 31.432.01.9%5.1%20.521.96.4%0.3%7.59.217.8%5.66.817.4% Lansen recorded a revenue of approximately US$31.4 million forthe six months ended 30 June 2023 (six months ended 30 June2022: approximately US$32.0 million), representing a decrease ofapproximately 1.9% over the corresponding period last year. Thedecrease in revenue was mainly due to the depreciation of Renminbi(“RMB”) against US$. Excluding such impact, the revenue increasedby approximately 5.1% as compared to the corresponding periodlast year. Gross profit was approximately US$20.5 million (six monthsended 30 June 2022: approximately US$21.9 million), representing adecrease of approximately 6.4% over the corresponding period lastyear. Excluding the effect of the depreciation of RMB against US$,gross profit increased by approximately 0.3% over the correspondingperiod last year. The decrease in gross profit margin was mainly dueto the increase in raw material costs. The profit from operations forthe period was approximately US$7.5 million (six months ended 30June 2022: approximately US$9.2 million), representing a decrease ofapproximately 17.8% as compared with the corresponding period lastyear, which was mainly due to the impact of the increase in sellingexpenses in addition to the impact of the decrease in gross profitmentioned above. The increase in selling expenses was due to thefact that the Group’s sales and marketing related activities could notbe fully carried out as planned in the first half of 2022 due to theimpact of the pandemic, and the low base in the first half of 2022led to an increase in sales and marketing expenses in the first half